HHS shields Emergent's anthrax drugs from lawsuits

10/10/2008 | American City Business Journals

Under the Public Readiness and Emergency Preparedness Act, the HHS secretary declared Emergent BioSolutions' anthrax products, Anthrax Immune Globulin and Biothrax vaccine, covered countermeasures to a public health crisis. The act, which is in effect until Dec. 31, 2015, will protect Emergent and other manufacturers from lawsuits to encourage them to develop treatments for anthrax and other serious health risks.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ